title: Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis.
abstract: There is conflicting evidence concerning the role of the bed nucleus of the stria terminalis (BNST) in fear and anxiety-elicited behavior. Most of the studies investigating this role, however, employed irreversible lesions of this nucleus. The objective of the present study was to investigate the effects of an acute and reversible inactivation of the BNST in rats submitted to the Vogel conflict test (VCT) and contextual fear conditioning, two widely employed animal models that are responsive to prototypal anxiolytic drugs. Male Wistar rats were submitted to stereotaxic surgery to bilaterally implant cannulae into the BNST. Ten minutes before the test they received bilateral microinjections of cobalt chloride (CoCl(2)) (1 mM/100 nL), a nonselective synapse blocker. CoCl(2) produced anxiolytic-like effects in tests, increasing the number of punished licks in the VCT and decreasing freezing behavior and the increase in mean arterial blood pressure and heart rate of animals re-exposed to the context where they had received electrical foot shocks 24 h before. The results indicate that the BNST is engaged in behavioral responses elicited by punished stimuli and aversively conditioned contexts, reinforcing its proposed role in anxiety.
authors.affiliation: Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, USP, Av. Bandeirantes 3900, 14049-900, Ribeirão Preto, São Paulo, 14049-900, Brazil. leoresstel@yahoo.com.br
authors.forename: L B M
authors.initials: LB
authors.lastname: Resstel
authors.forename: F H F
authors.initials: FH
authors.lastname: Alves
authors.forename: D G
authors.initials: DG
authors.lastname: Reis
authors.forename: C C
authors.initials: CC
authors.lastname: Crestani
authors.forename: F M A
authors.initials: FM
authors.lastname: Corrêa
authors.forename: F S
authors.initials: FS
authors.lastname: Guimarães
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001007:Anxiety / Q000139:chemically induced / Q000188:drug therapy / Q000523:psychology; D001362:Avoidance Learning / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D003035:Cobalt; D003220:Conflict, Psychological; D004326:Drinking / Q000187:drug effects; D005239:Fear / Q000187:drug effects*; D008297:Male; D008845:Microinjections; D009020:Morphine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D012686:Septal Nuclei / Q000187:drug effects*; D013238:Stereotaxic Techniques; D013569:Synapses / Q000187:drug effects
chemical_list: D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D003035:Cobalt; D009020:Morphine; C018021:cobaltous chloride; D002118:Calcium